Author: Jennifer Onyeagoro

JCBio appointed for Korea; Tekon Biotech appointed for China provide access to liver and small-intestine NAM screening with ā€œmolecules in, data outā€ speed and human relevanceSAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the ā€œCompanyā€ or ā€œVivoSim Labsā€), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced it has signed JCBio as an authorized distributor in Korea and Tekon Biotech as an authorized distributor inRead More

Read More